Ajay Goel

Active 2000–2025

246
Papers
35,956
Citations
106
h-index
239
i10-index

Citations

Citations per year for Ajay Goel1975: 2 citations1977: 1 citations1990: 1 citations1993: 2 citations1996: 1 citations1998: 1 citations2001: 6 citations2002: 11 citations2003: 28 citations2004: 54 citations2005: 78 citations2006: 67 citations2007: 86 citations2008: 112 citations2009: 165 citations2010: 220 citations2011: 240 citations2012: 279 citations2013: 266 citations2014: 318 citations2015: 358 citations2016: 367 citations2017: 391 citations2018: 420 citations2019: 1,429 citations2020: 1,647 citations2021: 1,673 citations2022: 1,579 citations2023: 1,252 citations2024: 1,831 citations2025: 1,036 citations2026: 27 citations1976: no citations, so this year is not shown1978–1989: no citations, so these years are not shown1991–1992: no citations, so these years are not shown1994–1995: no citations, so these years are not shown1997: no citations, so this year is not shown1999–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,166 citing papers, 25.1% of this breakdownUnited States: 2,950 citing papers, 17.8% of this breakdownItaly: 693 citing papers, 4.2% of this breakdownIndia: 682 citing papers, 4.1% of this breakdownIran: 574 citing papers, 3.4% of this breakdownUnited Kingdom: 569 citing papers, 3.4% of this breakdownGermany: 529 citing papers, 3.2% of this breakdownJapan: 503 citing papers, 3% of this breakdownSpain: 353 citing papers, 2.1% of this breakdownSouth Korea: 344 citing papers, 2.1% of this breakdownAustralia: 335 citing papers, 2% of this breakdownCanada: 313 citing papers, 1.9% of this breakdown
0%25.1%Other 27.7%

Fields

  • Biochemistry, Genetics and Molecular Biology57.3%
  • Medicine33%
  • Immunology and Microbiology2.4%
  • Agricultural and Biological Sciences1.8%
  • Neuroscience1%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Other3.6%

Topics

  • Cancer-related molecular mechanisms research5.6%
  • MicroRNA in disease regulation5.4%
  • Circular RNAs in diseases3.9%
  • Curcumin's Biomedical Applications3.7%
  • Genetic factors in colorectal cancer3.6%
  • RNA modifications and cancer3.3%
  • Other74.5%

Coauthors

All papers

Open in search
  1. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21

    Authors: , , , , , , , , , , , , , , , , , , , - Gastroenterology 2016 cited by 976

  2. Microsatellite Instability in Colorectal Cancer

    Authors: , - Gastroenterology 2010 cited by 2,470

  3. Epigenetics of colorectal cancer: biomarker and therapeutic potential

    Authors: , , , , - Nature Reviews Gastroenterology & Hepatology 2020 cited by 847

  4. Curcumin as “Curecumin”: From kitchen to clinic

    Authors: , , - Biochemical Pharmacology 2007 cited by 2,205

  5. Pathways of Colorectal Carcinogenesis

    Authors: , , - Gastroenterology 2019 cited by 592

  6. Non-coding RNAs and potential therapeutic targeting in cancer

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020 cited by 315

  7. Curcumin and colorectal cancer: An update and current perspective on this natural medicine

    Authors: , - Seminars in Cancer Biology 2020 cited by 311

  8. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2022 cited by 162

  9. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 199

  10. Ultrafast bisulfite sequencing detection of 5-methylcytosine in DNA and RNA

    Authors: , , , , , , , , , , - Nature Biotechnology 2024 cited by 142

  11. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma

    Authors: , , , , , , , , - Clinical Cancer Research 2019 cited by 199

  12. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer

    Authors: , , , , , , , , , , - Theranostics 2019 cited by 313

  13. Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome

    Authors: , , , , , , , , , , - Signal Transduction and Targeted Therapy 2021 cited by 192

  14. Circulating tumor DNA as an early cancer detection tool

    Authors: , , , , , , , , , , - Pharmacology & Therapeutics 2019 cited by 246

  15. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers

    Authors: , , - Gastroenterology 2015 cited by 815

  16. A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis

    Authors: , - Phytotherapy Research 2012 cited by 515

  17. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Florian Kühn, Luigi Laghi, Andrew Latchford, David Liska, Patrick M. Lynch, Alberto Malesci, Gianluca Mauri, Elisa Meldolesi, Pål Møller, Kevin Monahan, Gabriela Möslein, Caitlin C. Murphy, Karlijn J. Nass, Kimmie Ng, Cristina Oliani, Enrico Papaleo, Swati Patel, Marta Puzzono, Andrea Remo, Luigi Ricciardiello, Carla Ripamonti, Salvatore Siena, Satish K. Singh, Zsofia K. Stadler, Peter P. Stanich, Sapna Syngal, Stefano Turi, Emanuele Damiano Luca Urso, Laura Valle, Valeria Stella Vanni, Eduardo Vilar, Marco Vitellaro, Yiqian Nancy You, Matthew B. Yurgelun, Raffaella Alessia Zuppardo, Elena M. Stoffel - Clinical Gastroenterology and Hepatology 2022 cited by 125

  18. Circular RNA ciRS-7—A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer

    Authors: , , , , , , , , , - Clinical Cancer Research 2017 cited by 558

  19. Non-coding RNAs as liquid biopsy biomarkers in cancer

    Authors: , - British Journal of Cancer 2022 cited by 147

  20. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2019 cited by 298

  21. A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 262

  22. Epigenetic changes induced by curcumin and other natural compounds

    Authors: , , , , - Genes & Nutrition 2011 cited by 356

  23. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , - Gastroenterology 2023 cited by 85

  24. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis

    Authors: , , , , , , , - Theranostics 2022 cited by 77